Abstract 1572P
Background
The determinants of choices of orientation towards medical oncology have been little explored.
Methods
Medical students of the classes 2022 and 2023 in Lille and Amiens Universities (North of France) were enrolled in a quantitative online survey, with 2 follow-up over 2 months. 36 potential determinants from previous works (Wright et al. 2004; Beaulieu et al. 2010) were evaluated using a 5-point Likert scale alongside parameters. Choosing oncology was assessed among 44 specialities. We identified determinants using both CHAID method and binary and multiple linear regressions, and CHAID method.
Results
Responders were 563 (563/1250; 45%). CHAID analysis retained 2 factors: “medical oncology traineeship” (p<.0001) and “identification with a doctor in the specialty” (p=.049). when excluding factors associated with énd-cycle trining, CHAID analysis retained 2 factors associated with a career choice in oncology: “rejection of emergency care” (p=.036) and “wish of hospital-university career” (p=.006). Motivations differed according to sexes. In men, choosing oncology was associated in multivariate analysis with: “hospital traineeship in medical oncology” (β=0.22; p=.010), “hospital traineeship in oncology radiotherapy” (β=0.22; p<0.001) and “interest in fundamental research” (β=0.06; p<.001). Conversely, “rural life” (β=-0.09; p=.014) was negatively associated with this choice. In women, parameters positively associated with choosing oncology were: “hospital traineeship in medical oncology” (β=0.289; p<.001), “long-term relationship with patients” (β=0.12; p=.021) and “hospital work” (β=0.21; p=0<.001). A negative association was observed for: “treatment with visible outcome in the short term” (β=-0.15; p=.018) and “rural life” (β=-0.15; p=.006).
Conclusions
Motivations varied according to sexes. Hospital experience during the second cycle of medical studies plays a determining role. The ability or the interest in emergency management seems important in career choice. Certain interests influence career choice (long-term relationship with patient) as well as contextual factors (rural life). These results can be interpreted according to Bandura's social cognitive theory.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Centre Oscar Lambret.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1553P - Access to EMA approved drugs in Europe, disparities across a border
Presenter: Orla Fitzpatrick
Session: Poster session 10
1554P - Co payments in cancer patients: Analysis and estimating OOP
Presenter: Krishnamani Kalpathi
Session: Poster session 10
1555P - Estimating the social value of immuno-oncology (IO) therapies in Japan
Presenter: Tomoya Ohno
Session: Poster session 10
1556P - Current landscape of drug approvals for genitourinary (GU) cancers in North America and Europe
Presenter: Jose Tapia
Session: Poster session 10
1557P - The use of patient experience in UK NICE decision making in oncology
Presenter: Noemi Muszbek
Session: Poster session 10
1558P - Independent validation of the Breast Cancer Risk Assessment Tool (Gail model) for predicting breast cancer risk in Egyptian population
Presenter: Elaria Yacoub
Session: Poster session 10
1559P - Equity of access and clinical impact of genomic testing in patients with cancer in a UK early phase clinical trials unit
Presenter: Jonathan Poon
Session: Poster session 10
1560P - Optimal age versus real age in breast and gynaecological risk reducing surgery in BRCA1/2 carriers
Presenter: Alberta Ferrari
Session: Poster session 10
1561P - Targeted screening methodologies to select high risk individuals: LungFlag performance in Estonia Lung Cancer Screening Pilot
Presenter: Tanel Laisaar
Session: Poster session 10
1562P - The feasibility of polygenic risk score-based population screening for breast cancer: The experience from the BRIGHT study in Estonia
Presenter: Anni Lepland
Session: Poster session 10